Atezolizumab for Idiopathic Pulmonary Fibrosis
Clinical trial NCT05515627 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05515627
- Sponsor
- Cedars-Sinai Medical Center
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-02-15
- Primary completion
- 2026-06-30
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.